
LIVTENCITYâ„¢ (maribavir) receives positive CADTH recommendation for adults with post-transplant cytomegalovirus (CMV) infection
Ticker Tech,
LIVTENCITY™ (maribavir) receives positive CADTH recommendation for adults with post-transplant cytomegalovirus (CMV) infection…